TRUXIMA
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 98960062
- Mark type
- Design + words
- Filed
- 14 Jan 2025
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Kisuk Lee
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for the treatment of inflammations; pharmaceutical preparations for the treatment of transplant rejection; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of infectious diseases
Owner
- CELLTRION, INC., Incheon, KR
- CELLTRION, INC., Incheon, KR
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jun 2026 — ASSIGNED TO LIE
- 22 Jun 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 17 Apr 2026 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 17 Apr 2026 — INQUIRY TO SUSPENSION E-MAILED
- 17 Apr 2026 — SUSPENSION INQUIRY WRITTEN
- 15 Apr 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 22 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED